Influence of a single HELP application on hemorheology and retinal hemodynamics

Ophthalmologica

Volumn 210, Issue 3, 1996, Pages 171-174

  Haas, Anton ^a   Walzl, Manfred ^a   Eckhardt, Martin ^a   Walzl, Beringaria ^a   Faulborn, Jürgen ^a   Feigl, Beatrix ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Arteriovenous passage time; Fibrinogen; Hemorheology; Heparin induced extracorporeal low density lipoprotein precipitation (HELP); Retinal hemodynamics

Indexed keywords

FIBRINOGEN; HEPARIN;

ADULT; AGED; ARTICLE; BLOOD RHEOLOGY; FEMALE; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; RETINA BLOOD FLOW;

EID: 0029931016     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000310701     Document Type: Article

References (23)

1. Seidel D: T he HELP system: An efficient and safe method of plasma therapy in the treatment of severe hypercholesterolemia. Ther Umsch 1990:47:514-519.
2. Ramoling MW, Whittingstall P, Linderkamp O: The effects of fibrinogen and its plasmin degradation products on the rheology of erythrocyte suspension. Clin Hemorheol 1984:4:533-543.
3. Lesehke M, Blanke H, Stellwag M, Motz W, Strauer BE: Hyperftbrinogenamie und patho-logische Plasmaviskositat: Pathogenetische Faktoren bei der instabilcn Angina pectoris? Dtsch Med Wochenschr 1988:113:1175-1181.
4. Martin M, Hirdes E, Auel II: Defibrinogenation in patients suffering from severe intermittent claudication: A controlled study. Thromb Res 1976;9:47-57.
5. Ernst E: Hamorheologie.Theorie, Klinik. Therapie. Stuttgart. Schattauer, 1989, pp 78-82.
6. Lechner H, Walzl M, Walzl B, Leinert G, Kock T: The influence of HELP system in cerebrovascular disease, weighted on hemorheological factors. Med Biophys 1991;2:147-150.
7. Lechner H, Walzl M, Walzl B, Freidl W: HELP A possibility to change the hcmorheologic profile in cerebrovascular disease. Clin Hernorhcol 1992;12:705-711.
8. Walzl M, Lechner P, Walzl B: Application of HELP in PVOD - Preliminary results: in Ernst E, Koenig W. Lowe GDO. Meade TW (eds): Fibrinogen: A 'New' Cardiovascular Risk Factor. Vienna Blackwell-MZV. 1992. pp 419 422.
9. Walzl M, Walzl B, Niederkom K, Horner S, Lechner H: HELP application in reopening an internal carotid artery occlusion (abstract). Neuroimaging 1991:1:158-159.
10. Schuff-Werner P, Schutze E, Seyde W, Eisenhauer T, Janning G, Armstrong VW, Seidel D: improved hemorheology associated with a reduction in plasma fibrinogen and I.DL in patients being treated by heparin-induced extra-corporeal l. DL precipitation (HELP). Eur J Clin Invest 1989:19:30-37.
11. Richard GW: Differentiation of retinal circulation limes by videoangiography. Ophthalmologies 1985;191:161-163.
12. Jung F, Kiesewetter H, Korber N, Wolf S, Reim M, Muller G: Quantification of characteristic blood-flow parameters in the vessel of the retina with a picture analysis system for video-fluorescence angiograms: Initial findings. Gracfes Arch Clin Exp Ophthalmol 1983;221:133-136.
13. Daniel WW: Biostatistics: A Foundation for Analysis in Health Sciences, ed 5. New York, Wiley, 1991, pp 586-592.
14. Dintenfass L, Kainmer S: Plasma viscosity in 615 subjects: Effects of fibrinogen, globulin and cholesterol in normals, peripheral vascular disease, retinopathy, and melanoma. Biorheology 1977;14:247-251.
15. Kannel WB, Dagostino RB, Wilson PWF, Belanger AJ, Gagno DR: Diabetes, fibrinogen and risk of cardiovascular disease: The Framingham experience. Am Heart J 1990:120:672-676.
16. Sadoshima S, Tanaka K: Fibrinogen and low density lipoprotein in the development of cerebral arteriosclerosis. Arteriosclerosis 1979:34: 93-103.
17. Wilhelmsen L, Svardsudd K, Korsan-Bengsten K, Larrson B, Welin L, Tibblin G: Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984;311:501-505.
18. Seplowitz AH, Chien S, Smith FR: Effects of lipoproteins on plasma viscosity. Arteriosclerosis 1981:38:89-95.
19. Kleophas W, Leschke M, Tschope D: Akute Wirkung der extrakorporalen LDL-Choleste-rin- und Fibrinogen-Elimination auf Blutrhcol-ogie und Mikrozirkulation. Dtsch Med Wo-chenschr 1990; 115:3-7.
20. Wolf S, Arend O, Bertram B, Schulte K, Kaufhold F, Teping C, Reim M: Hamodilution bei Patienten mit Zentralvenenthrombosen der Retina. Fortschr Ophthalmol 1991;88:35-43.
21. Wolf S, Schulte-Strake U, Bertram B, Schulte K, Arend O, Reim M: Hamodilutionstherapie bei Patienten mit akuter vorderer ischamischer Optikusneuropathic. Fortschr Ophthalmol 1993:90:21-26.
22. Watanabe K. Ishida T, Yoshitomi F, Tanaka K: Fibrinogen degradation products influence PGI; synthesis by cultured porcine aortic endo-theliaand smooth muscle cells. Atherosclerosis 1984;51:151-161.
23. Schulff-Werner P, Schutze E, Eisenhauer T, Armstrong VW: Long-term fibrinogen lowering therapy by regular LDL/fibrinogen precipitation with the HELP system; in Ernst E, Koenig W, Lowe GDO. Meade TW (eds): Fibrinogen: A 'New’ Cardiovascular Risk Factor. Vienna Blackwell-MZV, 1992. Pp 403-407.